ABSTRACT
Data on sales and exports obtained for the pharmaceutical firms reveal that export intensity increased from about 19% in 1999 to about 41% in 2010. Since the computed export intensity is affected by the entry and exit of firms, it is would be useful to examine the export intensity of firms for which data could be found for all 12 years under study. The export intensity computed for these firms is shown in Figure 4. The export intensity of this group of firms increased from about 22% in 1999 to about 42% in 2010. Within this group, about 18% firms exported more than 50% of their output in 1999. This proportion rose to 26% of firms in 2010.
